“Seminal” study gene edits immune cells to target cancer
In a new study described by one oncologist as “seminal” and “pioneering”, researchers in the United States have successfully used CRISPR gene-editing technology to create personalized cancer-targeting immune cells. In a Phase 1 trial the researchers te… Continue reading “Seminal” study gene edits immune cells to target cancer
